NCT04384679
Withdrawn
Phase 4
The Evaluation of Topical Hemostatic Powder Containing Hydrophilic Polymer With Potassium Ferrate for Hemostasis Following Nail Surgery
ConditionsNail Diseases
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Nail Diseases
- Sponsor
- Weill Medical College of Cornell University
- Locations
- 1
- Primary Endpoint
- Time (in seconds) to bleeding cessation with hydrophilic polymer and potassium ferrate; time (in seconds) to bleeding cessation with direct pressure with sterile gauze
- Status
- Withdrawn
- Last Updated
- 3 years ago
Overview
Brief Summary
The purpose of this study is to assess the efficacy and safety of topical hemostatic powder containing hydrophilic polymer with potassium ferrate for bleeding control after nail surgical procedures
Investigators
Eligibility Criteria
Inclusion Criteria
- •At least 18 years old
- •Patients scheduled for any type of nail surgical procedure
- •Willingness to participate in the study
- •Ability to understand all instructions in the English language
Exclusion Criteria
- •Failure to have nail surgery performed
- •Likely inability to comply with the study protocol or cooperate fully with the research team
Outcomes
Primary Outcomes
Time (in seconds) to bleeding cessation with hydrophilic polymer and potassium ferrate; time (in seconds) to bleeding cessation with direct pressure with sterile gauze
Time Frame: Baseline
Time (in seconds) will be measured from application of intervention/nonintervention until bleeding cessation
Secondary Outcomes
- Number of participants with at least one adverse event(End of study (28 days))
Study Sites (1)
Loading locations...
Similar Trials
Completed
Phase 3
Safety and Hemostatic Efficacy of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated (FS VH S/D) Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac SurgeryCardiac Surgery Requiring Cardiopulmonary Bypass and Median SternotomyCardiopulmonary BypassSternotomyNCT00161733Baxter Healthcare Corporation
Active, not recruiting
Not Applicable
Random Evaluation of Patients Who Have Had Laparoscopic Partial NephrectomyKidney CancerNCT04120805University of Chicago178
Terminated
Not Applicable
Hemostatic Powder Versus Clinical Management for the Treatment of Upper Gastrointestinal Bleeding From Tumor LesionsGastrointestinal HemorrhageGastrointestinal NeoplasmsNCT02820077Instituto do Cancer do Estado de São Paulo62
Completed
Not Applicable
The use of a biologic topical haemostatic agent (TachoSil®) for the prevention of postoperative bleeding in patients on antithrombotic therapy undergoing thyroid surgeryISRCTN30172374niversity of Cagliari70
Recruiting
Not Applicable
Effectiveness and safety of hemostatic powder for patients who treated with prostate biopsyFactors influencing health status and contact with health servicesKCT0008584Chung-Ang Univerisity Hospital95